Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...

Although the semaglutide group had significantly more weight loss than the placebo group, results were comparable to STEP 1, indicating that IBT had not substantially affected the outcomes.

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Once boasting up to five million subscribers and backed by the likes of Oprah Winfrey, the company is now trying to shed debt ...

Positive Phase 2b QUALITY clinical study: Enobosarm in combination with GLP-1 RA drugs makes weight reduction more tissue selective for fat loss ... semaglutide group (p=0.0505). Topline Results ...

Lorraine Kelly and Jessica Simpson among the famous endorsers - the ease and accessibility of the new generation of semaglutide weight-loss jabs blew a hole in its business model. Even though it ...

Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

CHARLOTTE — Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported successful results ... Malya said. Semaglutide is the active ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...